Immunome's Debt - IV Round

Immunome raised a round of funding on October 15, 2014. Investors include Robin Hood Ventures.

Immunome is a start-up biopharmaceutical company with a patented native, human antibody platform which enables the company to harness the natural curative power of the human immune system. The Immunom…

Articles about Immunome's Debt - IV Round: